VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+10.2%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$323M
AUM Growth
+$323M
(-25%)
Cap. Flow
-$94.3M
Cap. Flow
% of AUM
-29.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Ventyx Biosciences
VTYX
|
$50.8M |
| 2 |
Akero Therapeutics
AKRO
|
$20.3M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$18.2M |
| 4 |
Harmony Biosciences
HRMY
|
$4.97M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ventyx Biosciences
VTYX
$171M
| $114M | 35.19% | 3,461,536 -1,550,000 | -31% | -$50.8M |
|
2
ALX Oncology
ALXO
$62.7M
| $109M | 33.89% | 9,699,925 | – | – |
|
|
3
Harmony Biosciences
HRMY
$2.12B
| $57.1M | 17.69% | 1,035,396 -90,277 | -8% | -$4.97M |
|
4
Pharvaris
PHVS
$1.39B
| $25.8M | 8.01% | 2,296,710 | – | – |
|
|
IMPL
5
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $10.3M | 3.21% | 2,759,791 | – | – |
|
|
CINC
6
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $4.71M | 1.46% | 383,390 -1,478,866 | -79% | -$18.2M |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| $1.77M | 0.55% | 1,866,339 | – | – |
|
|
8
Akero Therapeutics
AKRO
$3.74B
| – | – | -596,483 | Closed | -$20.3M |
|